roflumilast 250 ug (TABLET)
|
$8.5871
|
|
VA Big4
|
|
Daliresp (28) |
ASTRAZENECA PHARMACEUTICALS LP |
|
roflumilast 250 ug (TABLET)
|
$8.6820
|
|
VA Big4
|
|
Daliresp (20) |
ASTRAZENECA PHARMACEUTICALS LP |
|
roflumilast 250 ug (TABLET)
|
$11.8950
|
|
VA FSS
|
|
Daliresp (20) |
ASTRAZENECA PHARMACEUTICALS LP |
|
roflumilast 250 ug (TABLET)
|
$11.8979
|
|
VA FSS
|
|
Daliresp (28) |
ASTRAZENECA PHARMACEUTICALS LP |
|
roflumilast 250 ug (TABLET)
|
$12.6469
|
|
NADAC
|
brand
|
Daliresp (1) |
AstraZeneca Pharmaceuticals LP |
|
roflumilast 500 ug (TABLET)
|
$8.3216
|
|
VA Big4
|
|
Daliresp (90) |
ASTRAZENECA PHARMACEUTICALS LP |
|
roflumilast 500 ug (TABLET)
|
$8.4690
|
|
VA Big4
|
|
Daliresp (30) |
ASTRAZENECA PHARMACEUTICALS LP |
|
roflumilast 500 ug (TABLET)
|
$11.8973
|
|
VA FSS
|
|
Daliresp (30) |
ASTRAZENECA PHARMACEUTICALS LP |
|
roflumilast 500 ug (TABLET)
|
$11.8978
|
|
VA FSS
|
|
Daliresp (90) |
ASTRAZENECA PHARMACEUTICALS LP |
|
roflumilast 500 ug (TABLET)
|
$12.6636
|
|
NADAC
|
brand
|
Daliresp (1) |
AstraZeneca Pharmaceuticals LP |
|